Page last updated: 2024-10-22

alendronate and Purpura, Thrombocytopenic, Idiopathic

alendronate has been researched along with Purpura, Thrombocytopenic, Idiopathic in 1 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Purpura, Thrombocytopenic, Idiopathic: Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nomura, S1
Kurata, Y1
Tomiyama, Y1
Takubo, T1
Hasegawa, M1
Saigo, K1
Nishikawa, M1
Higasa, S1
Maeda, Y1
Hayashi, K1

Other Studies

1 other study available for alendronate and Purpura, Thrombocytopenic, Idiopathic

ArticleYear
Effects of bisphosphonate administration on the bone mass in immune thrombocytopenic purpura patients under treatment with steroids.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2010, Volume: 16, Issue:6

    Topics: Adult; Aged; Alendronate; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Gl

2010